Position in SYRE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$85,992,130
+$44,702,047 QoQ
Shares Held
968,598
+18.3% QoQ
Ownership
1.10%
of shares outstanding
% of Portfolio
1.75%
of 13F equity value
Holder Rank
#28
of 266 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SYRE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Siren, L.L.C. holds $4,562,402,933 across 78 Biotechnology names. SYRE ranks #14 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SRRK |
Scholar Rock Holding Corp
|
9,575,013 | $526,625,715 | |
| 2 | KYMR |
Kymera Therapeutics, Inc.
|
2,935,830 | $336,651,626 | |
| 3 | ERAS |
Erasca, Inc.
|
11,397,781 | $208,807,347 | |
| 4 | MANE |
Veradermics, Inc
|
1,655,374 | $203,511,679 | |
| 5 | TNGX |
Tango Therapeutics, Inc.
|
6,179,364 | $193,166,918 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
900,000 | $168,552,000 | |
| 7 | BCAX |
Bicara Therapeutics Inc.
|
5,602,970 | $166,352,179 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
1,715,476 | $139,828,448 |
All Filings in SYRE
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $85,992,130 | 968,598 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $41,290,083 | 818,598 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $26,817,270 | 818,598 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $6,177,702 | 368,598 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $5,517,912 | 368,598 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $5,947,328 | 368,598 | Shares | Defined | 2025-05-23 | |
| 2024-12-31 | $8,706,720 | 374,000 | Shares | Defined | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||